An analysis of time to treatment in patients with pancreatic adenocarcinoma.
Publication/Presentation Date
7-1-2023
Abstract
BACKGROUND: Currently, no guidelines exist regarding the appropriate time from diagnosis to treatment among pancreatic adenocarcinoma patients. Herein, we aim to define the median time to treatment in pancreatic adenocarcinoma, factors associated with treatment delay, and prognostic significance.
METHODS: We conducted a retrospective study of pancreatic adenocarcinoma patients, stage I-IV, at a tertiary referral center (2017-2020). We subdivided time to treatment (days) into 4 components: (1) T
RESULTS: In total, 217 patients met the inclusion criteria. The median T
CONCLUSION: It takes a median time of less than a month for a patient with pancreatic adenocarcinoma to start treatment, even after they visit a primary provider. The greatest opportunity to shorten the overall time to treatment is by having patients seek medical attention earlier (T
Volume
174
Issue
1
First Page
83
Last Page
90
ISSN
1532-7361
Published In/Presented At
Sugumar, K., Gendi, S., Quereshy, H. A., Gupta, S., Hue, J. J., Rothermel, L. D., Ocuin, L. M., Ammori, J. B., Hardacre, J. M., & Winter, J. M. (2023). An analysis of time to treatment in patients with pancreatic adenocarcinoma. Surgery, 174(1), 83–90. https://doi.org/10.1016/j.surg.2023.03.011
Disciplines
Medicine and Health Sciences
PubMedID
37105784
Department(s)
Department of Surgery, Lehigh Valley Topper Cancer Institute
Document Type
Article